Mycophenolic acid (Compound)

Synonyms:mycophenolic acid, 24280-93-1, Mycophenolate, Melbex, Myfortic, Mycophenolsaeure, Lilly-68618, 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid, 483-60-3, Acido micofenolico, Micofenolico acido, NSC-129185, Acide mycophenolique, Acidum mycophenolicum, (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid, CCRIS 5565, NSC 129185, UNII-HU9DX48N0T, (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid, Ly 68618, (E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid, (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid, 6-(1,3-Dihydro-7-hydroxy-5-methoxy-4-methyl-1-oxoisobenzofuran-6-yl)-4-methyl-4-hexanoic acid, MFCD00036814, Lilly 68618, CHEMBL866, HU9DX48N0T, CHEBI:168396, TNP00198, RS-61443 [AS MOFETIL], NSC129185, 4-Hexenoic acid, 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-, (E)-, 4-Methyl-5-methoxy-7-hydroxy-6-(5-carboxy-3-methylpent-2-en-1-yl)-phthalide (E)-, 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid (E)-, 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-, NCGC00016786-01, CAS-24280-93-1, 6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methylhex-4-enoic acid, DSSTox_CID_21070, DSSTox_RID_79619, DSSTox_GSID_41070, Mycophenolic acid-d3 solution, Mycophenoic acid, Micofenolico acido [Spanish], (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid, 6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid, MOA, SMR000471887, Acido micofenolico [INN-Spanish], Acide mycophenolique [INN-French], Acidum mycophenolicum [INN-Latin], SR-01000597602, EINECS 246-119-3, mycophenolic-acid, 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid, Prestwick_817, EINECS 207-595-8, Mycophenolic acid [USAN:INN:BAN], Tocris-1505, (Z)-Mycophenolic Acid, 1jr1, Mycophenolic acid (TN), Prestwick2_000556, Prestwick3_000556, Spectrum5_001654, Mycophenolic Acid (MPA), Mycophenolic acid solution, UPCMLD-DP028, 4-Hexenoic acid, (E)-, EC 246-119-3, Mycophenolate;RS-61443, SCHEMBL4549, Mycophenolic (Mycophenolate), Mycophenolic acid, >=98%, BSPBio_000631, BSPBio_002534, MLS001074701, MLS002222265, MLS002695945, BIDD:GT0456, SPECTRUM1500674, BPBio1_000695, GTPL6832, MEGxm0_000120, Mycophenolic acid (USAN/INN), Myfortic (mycophenolate sodium), SCHEMBL2514376, ZINC1758, DTXSID4041070, UPCMLD-DP028:001, ACon0_000960, ACon1_000496, BDBM19264, CHEBI:92545, HMS500H08, AOB5506, EX-A975, HMS1569P13, HMS1921A18, HMS2089A17
Id:446541
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Mycophenolic acid's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Mycophenolic acid.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Mycophenolic acid.

Results found

Linked to

 

Label

Description

 

Collection

DrugPage Collection: (DrugCentralID:01860; PubChem_CID:446541, FILE=drugcentral_drug_01860.json)

Collection

Metadatata for mycophenolic acid

Substance

A Substance

Collection

DrugPage Collection: (DrugCentralID:01859; PubChem_CID:446541, FILE=drugcentral_drug_01859.json)

  • Collection

    DrugPage Collection: (DrugCentralID:01860; PubChem_CID:446541, FILE=drugcentral_drug_01860.json)




  • Collection

    DrugPage Collection: (DrugCentralID:01859; PubChem_CID:446541, FILE=drugcentral_drug_01859.json)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.